SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-012621
Filing Date
2017-11-08
Accepted
2017-11-08 17:23:25
Documents
33
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 365373
2 ex31-1.htm EX-31.1 18181
3 ex31-2.htm EX-31.2 11619
4 ex32.htm EX-32 4713
  Complete submission text file 0001493152-17-012621.txt   1579097

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pvct-20170930.xml EX-101.INS 142614
6 XBRL SCHEMA FILE pvct-20170930.xsd EX-101.SCH 19007
7 XBRL CALCULATION FILE pvct-20170930_cal.xml EX-101.CAL 31065
8 XBRL DEFINITION FILE pvct-20170930_def.xml EX-101.DEF 72080
9 XBRL LABEL FILE pvct-20170930_lab.xml EX-101.LAB 158631
10 XBRL PRESENTATION FILE pvct-20170930_pre.xml EX-101.PRE 115069
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36457 | Film No.: 171187583
SIC: 2834 Pharmaceutical Preparations